Companies:
53,593
Total Market Cap:
173016516872983.12
AFT Pharmaceuticals Limited
ASX-AFP
Healthcare
Drug Manufacturers - Specialty & Generic
Global Rank
#19700
Country Rank
#49
Market Cap
263.35 M
Price
2.46
Change (%)
1.86%
Volume
65
AFT Pharmaceuticals Limited's latest marketcap:
263.35 M
As of 09/12/2026, AFT Pharmaceuticals Limited's market capitalization has reached $263.35 M. According to our data, AFT Pharmaceuticals Limited is the 19700th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 263.35 M |
| Revenue (ttm) | 152 M |
| Net Income (ttm) | 8.79 M |
| Shares Out | 0 |
| EPS (ttm) | 0.08 |
| Forward PE | 23.00 |
| Ex-Dividend Date | 06/18/2026 |
| Earnings Date | 11/19/2026 |
Market Cap Chart
Data Updated: 09/12/2026
AFT Pharmaceuticals Limited's yearly market capitalization.
AFT Pharmaceuticals Limited has seen its market value grow from A$288.06 M to A$367.4 M since 2015, representing a total increase of 27.54% and an annual compound growth rate (CAGR) of 2.30%.
| Date | Market Cap(A$) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 09/12/2026 | A$367.4 M | $263.35 M | 8.09% | 19700 |
| 12/31/2025 | A$305.73 M | $199.98 M | 11.08% | 20589 |
| 12/31/2024 | A$275.23 M | $170.27 M | -19.28% | 19971 |
| 12/29/2023 | A$340.95 M | $232.12 M | -4.96% | 17924 |
| 12/29/2022 | A$358.75 M | $244.4 M | -18.74% | 16843 |
| 12/31/2021 | A$441.47 M | $320.28 M | -17.88% | 16072 |
| 12/31/2020 | A$537.56 M | $0 | 64.48% | 12668 |
| 12/31/2019 | A$326.83 M | $229.27 M | 64.86% | 14111 |
| 12/17/2018 | A$198.25 M | $139.72 M | -2.06% | 15607 |
| 12/29/2017 | A$202.42 M | $158.06 M | -21.06% | 15699 |
Company Profile
AFT Pharmaceuticals Limited was founded in 1997 in New Zealand.
on the Australian Securities Exchange.
With 126 employees, it focuses on Healthcare and aims to drive innovation in Drug Manufacturers - Specialty & Generic.
Frequently Asked Questions
-
What is AFT Pharmaceuticals Limited's (ASX-AFP) current market cap?As of 09/12/2026, AFT Pharmaceuticals Limited (including the parent company, if applicable) has an estimated market capitalization of $263.35 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does AFT Pharmaceuticals Limited (ASX-AFP) rank globally by market cap?AFT Pharmaceuticals Limited global market capitalization ranking is approximately 19700 as of 09/12/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.